ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Lithium Carbonate

Also written as “lithium carbonate”, “Lithium carbonate” and “Lithium Carbonate Capsule”.

Its studies are mostly in Depressive Disorder, Major · Bipolar Disorder, led by 5 companies.

Drug pageLithium Carbonate: every studyMany companies study it; this page follows only the 5 they lead. All 61 studies, academic ones too, with its approvals and label.
Furthest: phase 3, since Nov 11, 20085 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AstraZenecaits history only10 open or runningphase 3since Nov 11, 2008Nov 11, 2008none ahead
Columbia Northwest Pharmaceuticalsits history only10 open or runningphase 2since Mar 18, 2010Mar 18, 2010none ahead
Eli Lillyits history only10 open or runningphase 3since Jun 11, 2007Jun 11, 2007none ahead
JDS Pharmaceuticals10 open or runningphase 3since Jan 11, 2007Jan 11, 2007none ahead
Merckits history only10 open or runningphase 1since Dec 2, 2024Dec 2, 2024none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of JDS Pharmaceuticals only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 11, 2007First study: phase 3 study in Bipolar DisorderFirst studyNCT00422331 · 206 enrolled · United States

TargetBeta

“Inositol-1(or 4)-monophosphatase 1 inhibitor; Glycogen synthase kinase-3 inhibitor”ChEMBL 37, by rule

Studies

The one study JDS Pharmaceuticals leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT00422331Bipolar Disorder · United States3UNKNOWN206

How it is read

Names in the registry

  • “Lithium Carbonate”, 2 entries
  • “lithium carbonate”, 1 entry
  • “Lithium carbonate”, 1 entry
  • “Lithium Carbonate Capsule”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.